Pavadi Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$8.19M Buy
+17,374
New +$8.03M 10.09% 1
2023
Q1
Sell
-8,834
Closed -$4.53M 19
2022
Q4
$4.53M Buy
8,834
+488
+6% +$248K 4.27% 16
2022
Q3
$3.79M Sell
8,346
-803
-9% -$384K 3.63% 16
2022
Q2
$4.42M Buy
9,149
+1,455
+19% +$720K 4% 16
2022
Q1
$3.78M Sell
7,694
-1,182
-13% -$540K 3.33% 19
2021
Q4
$4.11M Buy
+8,876
New +$3.73M 3.12% 21

Other funds holding ELV

Pavadi Capital's ELV Position: Q4 2023 in Review

Pavadi Capital opened a new position in Elevance Health (ELV) in Q4 2023: 17,374 shares worth $8.19M. The stake represents 10.09% of the portfolio and ranks #1 among its holdings. This is a return to the name: Pavadi Capital previously reported a position in ELV as recently as Q4 2022.

Pavadi Capital first reported a position in ELV in Q4 2021 and has held it in 6 quarters since. 1,656 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Pavadi Capital held 17,374 shares of Elevance Health worth $8.19M as of Q4 2023.
  • Elevance Health was a new Pavadi Capital position in Q4 2023.
  • Elevance Health made up 10.09% of Pavadi Capital's portfolio in Q4 2023, its #1 holding.
  • Pavadi Capital first reported a position in Elevance Health in Q4 2021 and has held it in 6 quarters since.
  • 1,656 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.